Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1069147]Researchers: Prof Alicia Jenkins (Principal investigator) , Prof David O'Neal , Prof James Best , Prof Kim Donaghue
Brief description Diabetes is one of the commonest cause of blindness in adults. Vision loss, which is irreversible, is a most feared complication of diabetes. A blood fat lowering drug called fenofibrate, available in Australia, has been shown to reduce eye damage in people with Type 2 diabetes by 35-40%, and to prevent eye damage in Type 1 diabetic animal models. This study will evaluate the potential benefits of fenofibrate in 450 adults with Type 1 diabetes who have early diabetic eye damage.
Funding Amount $AUD 2,883,529.09
Funding Scheme Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1069147
- nhmrc : 1069147